Systemic reactogenicity following homologues and heterologous prime-boost AZD1222 and BNT162b2 COVID-19 vaccination of 2862 healthcare workers compared with an unvaccinated population

被引：0

作者：

Tabatabaeifar, Sorosh ^{[1
]}

Vestergaard, Jesper M. ^{[1
]}

Wurtz, Else T. ^{[1
]}

Hansen, Karoline K. ^{[1
]}

Nielsen, Kent J. ^{[2
]}

Schlunssen, Vivi ^{[3
]}

Kolstad, Henrik A. ^{[1
,4
]}

机构：

[1] Aarhus Univ Hosp, Danish Ramazzini Ctr, Dept Occupat Med, Aarhus, Denmark

[2] Goedstrup Hosp, Danish Ramazzini Ctr, Dept Occupat Med, Herning, Denmark

[3] Aarhus Univ, Danish Ramazzini Ctr, Dept Publ Hlth Environm Work & Hlth, Aarhus, Denmark

[4] Aarhus Univ, Dept Clin Med, Aarhus, Denmark

来源：

VACCINE: X | 2023年 / 13卷

关键词：

COVID-19; vaccine; Systemic reactogenicity; Vaccine safety; Cohort study; Healthcare workers;

D O I：

10.1016/j.jvacx.2023.100280

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

During spring 2021, AZD1222 and BNT162b2 were used as prime and BNT162b2 as booster COVID-19 vaccines in Denmark. We obtained self-reported information on systemic reactogenicity day-by-day during two weeks for 2862 healthcare workers vaccinated with heterologous AZD1222 + BNT162b2 or homologous BNT162b2 + BNT162b2 regimens and compared prevalences of symptoms with unvaccinated healthcare workers. We found comparable systemic reactogenicity during the first week in the two vaccine regimens and no reactogenicity during the second week. Most of the symptoms returned to a level equal to the control population four days after booster vaccination.(c) 2023 The Author(s). Published by Elsevier Ltd. This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).

引用

页数：4

共 50 条

[21] Persistence of Anti-S Titre among Healthcare Workers Vaccinated with BNT162b2 mRNA COVID-19 [J].

Coppeta, Luca ;

Somma, Giuseppina ;

Ferrari, Cristiana ;

Mazza, Andrea ;

Rizza, Stefano ;

Aurilio, Marco Trabucco ;

Perrone, Stefano ;

Magrini, Andrea ;

Pietroiusti, Antonio .

VACCINES, 2021, 9 (09)

[22] Higher SARS-CoV-2 Spike Binding Antibody Levels and Neutralization Capacity 6 Months after Heterologous Vaccination with AZD1222 and BNT162b2 [J].

Mueller-Hilke, Brigitte ;

Mai, Franz ;

Mueller, Michael ;

Volzke, Johann ;

Reisinger, Emil C. .

VACCINES, 2022, 10 (02)

[23] Local and systemic reactogenicity of COVID-19 vaccine BNT162b2 in patients with systemic lupus erythematosus and rheumatoid arthritis [J].

Lars Erik Bartels ;

Christian Ammitzbøll ;

Jakob Bøgh Andersen ;

Signe Risbøl Vils ;

Clara Elbæk Mistegaard ;

Anders Dahl Johannsen ;

Marie-Louise From Hermansen ;

Marianne Kragh Thomsen ;

Christian Erikstrup ;

Ellen-Margrethe Hauge ;

Anne Troldborg .

Rheumatology International, 2021, 41 :1925-1931

[24] Local and systemic reactogenicity of COVID-19 vaccine BNT162b2 in patients with systemic lupus erythematosus and rheumatoid arthritis [J].

Bartels, Lars Erik ;

Ammitzboll, Christian ;

Andersen, Jakob Bogh ;

Vils, Signe Risbol ;

Mistegaard, Clara Elbaek ;

Johannsen, Anders Dahl ;

Hermansen, Marie-Louise From ;

Thomsen, Marianne Kragh ;

Erikstrup, Christian ;

Hauge, Ellen-Margrethe ;

Troldborg, Anne .

RHEUMATOLOGY INTERNATIONAL, 2021, 41 (11) :1925-1931

[25] COVID-19 Vaccination and Asymptomatic Infection Effect of BNT162b2 mRNA Vaccine on the Incidence of COVID-19 and Duration of Sick Leave Among Healthcare Workers [J].

Prato, Simone ;

Paladino, Maria Emilia ;

Riva, Michele Augusto ;

Belingheri, Michael .

JOURNAL OF OCCUPATIONAL AND ENVIRONMENTAL MEDICINE, 2021, 63 (12) :E868-E870

[26] Risk of myocarditis and pericarditis following BNT162b2 and mRNA-1273 COVID-19 vaccination [J].

Goddard, Kristin ;

Lewis, Ned ;

Fireman, Bruce ;

Weintraub, Eric ;

Shimabukuro, Tom ;

Zerbo, Ousseny ;

Boyce, Thomas G. ;

Oster, Matthew E. ;

Hanson, Kayla E. ;

Donahue, James G. ;

Ross, Pat ;

Naleway, Allison ;

Nelson, Jennifer C. ;

Lewin, Bruno ;

Glanz, Jason M. ;

Williams, Joshua T. B. ;

Kharbanda, Elyse O. ;

Yih, W. Katherine ;

Klein, Nicola P. .

VACCINE, 2022, 40 (35) :5153-5159

[27] Vestibular disorders following BNT162b2 mRNA COVID-19 vaccination: A retrospective case series [J].

Ammar, Helmi ;

Le Beller, Christine ;

Bouccara, Didier ;

Malinvaud, David ;

Jouffroy, Romain ;

Lillo-Le Louet, Agnes .

FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2024, 38 (01) :192-204

[28] Does ChAdOx1-S and BNT162b2 heterologous prime-boost vaccination trigger higher rates of vaccine-related adverse events? [J].

Haji, Alhan ;

Alkattan, Abdallah ;

Mahmoud, Nagla ;

Elkagam, Elfadil ;

Hassanein, Mustafa ;

Alfaifi, Amal ;

Al-Tawfiq, Jaffar A. ;

Alabdulkareem, Khaled ;

Jokhdar, Hani ;

Radwan, Nashwa .

IJID REGIONS, 2023, 7 :159-163

[29] Real-world effectiveness of homologous and heterologous BNT162b2, CoronaVac, and AZD1222 booster vaccination against Delta and Omicron SARS-CoV-2 infection [J].

Suah, Jing Lian ;

Tng, Boon Hwa ;

Tok, Peter Seah Keng ;

Husin, Masliyana ;

Thevananthan, Thevesh ;

Peariasamy, Kalaiarasu M. ;

Sivasampu, Sheamini .

EMERGING MICROBES & INFECTIONS, 2022, 11 (01) :1343-1345

[30] Effectiveness of BNT162b2 COVID-19 Vaccine in Preventing Severe Symptomatic Infection among Healthcare Workers [J].

Murillo-Zamora, Efren ;

Trujillo, Xochitl ;

Huerta, Miguel ;

Rios-Silva, Monica ;

Mendoza-Cano, Oliver .

MEDICINA-LITHUANIA, 2021, 57 (08)

← 1 2 3 4 5 →